Apr 4, 2022
How a Seagen cancer drug with Nobel Prize science might also work in diabetes
Posted by Kelvin Dafiaghor in categories: biotech/medical, science
Some diabetes therapies work by ramping up the body’s secretion of insulin to counteract high blood sugar levels. | Preserving insulin-producing pancreatic beta cells—rather than exhausting them—might be a better strategy in the treatment of diabetes. Following that thinking, scientists at the Karolinska Institute found a cancer drug by Seagen holds promise for the metabolic disease.